(*) Denotes Nature article coauthor.
Executive Committee
- Robert Beaglehole (*), former Director, WHO Department for Health Promotion, Disease Prevention, Management and Surveillance, New Zealand
- John Bell (*), Regius Professor of Medicine, University of Oxford; Chair, Oxford Health Alliance, UK
- Alan Bernstein (*), President, Canadian Institutes of Health Research, Canada
- Sir Leszek K Borysiewicz (*), Chief Executive, Medical Research Council, UK
- Abdallah Daar (*), Senior Scientist and Co-director, Program on Life Sciences, Ethics and Policy, McLaughlin-Rotman Centre for Global Health; Professor of Public Health Sciences and of Surgery, University of Toronto, Canada
- Roger I. Glass (*), Director, Fogarty International Center, National Institutes of Health, USA
- Jeffrey Koplan (*), Vice President for Academic Health Affairs, Emory University, USA
Scientific Board
- Lucas Adetokunbo, Former Director, WB/WHO/UNDP/UNICEF Special Programme on Tropical Diseases Research and Training, Nigeria
- Sir George Alleyne, Professor Emeritus, University of the West Indies, Jamaica
- Stephen Colagiuri (*), Professor of Metabolic Health, University of Sydney, Australia
- Diane T. Finegood (*), Scientific Director, Canadian Institutes of Health Research, Institute of Nutrition, Metabolism and Diabetes, Canada
- Ray Fitzpatrick, Faculty Fellow and Dean, Professor of Public Health and Primary Care, University of Oxford, UK
- Julio Frenk, Former Secretary of Health, Mexico; Bill and Melinda Gates Foundation, Mexico
- Nirmal Ganguly (*), Director General, Indian Council of Medical Research, India
- Harold Jaffe, Professor of Public Health, University of Oxford, UK
- Catherine Le Gales-Camus, former Assistant Director-General, Non-communicable Diseases and Mental Health, WHO, Switzerland
- Stephen Leeder, Director, Australian Health Policy Institute & University of Sydney, Australia
- Alan Lopez, Director, Population Health, University of Queensland, Australia
- Adel Mahmoud, Professor, Woodrow Wilson School of Public and International Affairs, Princeton University, USA
- David R. Matthews (*), Chairman, Oxford Centre for Diabetes, Endocrinology and Metabolism, Professor of Diabetic Medicine, University of Oxford, UK
- Elizabeth G. Nabel (*), Director, National Heart, Lung, and Blood Institute, National Institutes of Health, USA
- Stig K. Pramming (*), Executive Director, The Oxford Health Alliance, UK
- George Sarna (*), Associate Director, Research Management Group, Medical Research Council, UK
- Nizal Sarrafzadegan (*), Professor of Medicine, Isfahan University of Medical Sciences, Iran
- Peter A. Singer (*), Co-director, Program on Life Sciences, Ethics and Policy, McLaughlin-Rotman Centre for Global Health; Professor of Medicine, University of Toronto, Canada
- Lars Rebien Sorensen, Chief Executive, Novo Nordisk A/S, Denmark
- Derek Yach (*), Director of Global Health Policy, PepsiCo, USA
- Lap-Chee Tsui, Vice President, University of Hong Kong, China
- Richard Smith (*), Director, Ovations Chronic Disease Initiative, Former Editor, British Medical Journal, UK.
Also coauthoring the Nature article:
- Deepa Leah Persad (*), Program Research Coordinator, McLaughlin-Rotman Centre for Global Health, Toronto, Canada